The table below lists the adverse events that have been reported in two double-blind, placebo-controlled trials in patients on chronic hemodialysis
Ethical and Accessibility Concerns: With the spotlight on GLP-1 drugs, questions regarding equitable access to these potentially life-altering medications come to the forefront
Salazar JF, Herbeth B, Siest G, Leroy P
In a research log or simple spreadsheet, note the peptide name, reconstitution date, bacteriostatic water used, volume added, resulting concentration, storage location, and expected discard date
This is the foundation
Despite conflicting data, subjective measures consistently reveal that individuals report feelings of sleepiness, longer sleep duration, and quicker sleep onset with DSIP